About Cebis India Limited
Data last updated:
Cebis India Limited is a public limited company based in Secunderabad, Telangana, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 10 October 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U73100TG2018PLC127550. Its GSTIN is 36AAGCV6316F1ZB (Telangana). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹15.5 Cr and a paid-up capital of ₹15.07 Cr. It is led by directors including Dopesh Raja Mulakala (Managing Director) and Mulakala Sajan Kiran.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at No.02/G/308/G No.3/Ff/Sf/1 – 20 – 248 Umajay Complex Rasoolpura, Secunderabad, Telangana, India – 500003.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.22 Cr, a growth of 5% compared to the previous year. For the same year it recorded a net loss of ₹8.65 Cr and EBITDA of -₹2.27 Cr (EBITDA margin -185.4%). Revenue has grown at a compounded annual rate (CAGR) of 105% over three years and 94% over five years.
The company has about 37 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹19.97 Cr and satisfied charges of ₹53.63 Cr on record. Court records list 6 cases involving the company, including 1 filed by the company and 5 filed against it; 1 case is pending.
For more details, the company can be reached via its website vayamresearch.net.
Company details
Contact details
Cebis India Limited's registered office is in Secunderabad, Telangana. Its website is vayamresearch.net. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressNo.02/G/308/G No.3/Ff/Sf/1 – 20 – 248 Umajay Complex Rasoolpura, Secunderabad, Telangana, India – 500003
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Cebis India Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Cebis India is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Cebis India Limited, buy the company report.
Financials of Cebis India Limited
FY 2024 filings availableCebis India Limited reported revenue of ₹1.22 Cr (up 5% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 94% over five years, including 5% growth in the latest year. EBITDA fell 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2.27 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹8.65 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -185.4% | ||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cebis India Limited, buy the company report.
Board of directors and KMP of Cebis India Limited
Cebis India Limited currently reports 3 directors and 1 key managerial person. 7 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dopesh Raja Mulakala Also directs: Shree Cosmetics Limited, Vanta Clinical Research Limited, Vanta Bioscience Limited and 2 more | Managing Director | 10 Oct 2018 | 8 Years 0 Months | Current |
| Mulakala Sajan Kiran | Director | 11 Mar 2020 | 6 Years 7 Months | Current |
| Chintapatla Shravan | Director | 18 Aug 2020 | 6 Years 2 Months | Current |
| Yati Brijmohan Chugh | Ceo | 01 Jul 2020 | 6 Years 3 Months | Current |
Auditor
Cebis India Limited is audited by Italia & Associates LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Italia & Associates LLP | FY 2023 | 003793S |
Shareholding
The shareholding of Cebis India Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Cebis India Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Jun 2022 | 100595385 | Others | ₹19.5 Cr | Open | |
| 28 Jun 2022 | 100595386 | Others | ₹47 Lakh | Open | |
| 01 Sep 2021 | 100514855 | Others | ₹49.7 Lakh | Satisfied | |
| 30 Dec 2020 | 100404637 | Others | ₹15 Cr | Satisfied | |
| 01 Jul 2020 | 100353760 | State Bank of India | ₹21.13 Cr | Satisfied |
To see the full charge records of Cebis India Limited, buy the company report.
Total charge records: 6 View all charges
Legal cases
Cebis India Limited has 6 court cases on record: 1 filed by Cebis India, 5 filed against it. 1 case is pending and 5 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 5 | 5 | 1 |
| High courts | 1 | 0 | 0 |
Cases on record (4 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court | Court case (COARP) | Filed by the company against Emcure Pharmaceuticals Limited | Disposed |
| District court, Ahmedabad, Gujarat | Court case (RECO33C 2 LC) | Filed against the company by an individual | Pending |
| District court, Ahmedabad, Gujarat | Court case (CR EN) | Filed against the company by an individual | Disposed |
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed against the company by an individual | Disposed |
To see the full case history of Cebis India Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Cebis India Limited has 4 MSME Form 1 returns on record between 2019 and 2021, listing 4 overdue payments to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (1 of 1)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Hansley & Deora Corporate Advisors LLP |
To see the full MSME payment records of Cebis India Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Cebis India has 1 associated company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
Employees & EPFO
Cebis India Limited has a workforce of 37 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
GST
Cebis India has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAGCV6316F1ZB | Telangana | Active | 06 Jul 2019 |
| 24AAGCV6316F1ZG | Gujarat | Active | 28 Apr 2019 |
To see the full GST registrations and return filing status of Cebis India Limited, buy the company report.
Recent activity
Cebis India Limited has 11 board changes on record since 2018: 4 appointments and 7 cessations. The latest: Javali Sudhir Pai ceased to be Director on 10 Oct 2022.
12 earlier events are in the company report.
Frequently asked questions
Cebis India is an active public limited company based in Secunderabad, Telangana, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 10 October 2018 (8+ years old) and is registered under CIN U73100TG2018PLC127550.
Cebis India has 4 current directors and KMP:
- Dopesh Raja Mulakala - Managing Director
- Mulakala Sajan Kiran - Director
- Chintapatla Shravan - Director
- Yati Brijmohan Chugh - Ceo
The latest financial statements of Cebis India on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Cebis India is 36AAGCV6316F1ZB, registered in Telangana. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 24AAGCV6316F1ZG (Gujarat).
The CIN (Corporate Identification Number) of Cebis India is U73100TG2018PLC127550. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cebis India has 6 court cases on record: 1 filed by the company and 5 filed against it. 1 is pending. Most are in the district courts.
Cebis India was incorporated on 10 October 2018, making it 8+ years old. It is registered with the Registrar of Companies, Hyderabad.
Javali Sudhir Pai ceased to be Director on 10 Oct 2022. Chintapatla Shravan ceased to be Additional Director on 31 Dec 2020. Mulakala Sajan Kiran ceased to be Additional Director on 31 Dec 2020. Cebis India has 11 board changes on record in total.
Cebis India has 4 MSME Form 1 returns on record between 2019 and 2021, listing 4 overdue payments to 1 micro and small supplier. The latest return was filed on 18 May 2021.
Cebis India can be reached through the website vayamresearch.net. Its registered office is in Secunderabad, Telangana, India.
The registered office of Cebis India is at No.02G308G No.3FfSf1 – 20 – 248 Umajay Complex Rasoolpura, Secunderabad, Telangana, India – 500003.